▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Snap-On Q2 22 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 7/21/2022 6:02 AM ET

Snap-On Inc. (SNA) will host a conference call at 10:00 AM ET on July 21, 2022, to discuss Q2 22 earnings results.

To access the live webcast, log on to https://www.snapon.com/EN/Investors/Investor-Events

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Latest Updates on COVID-19

34% Fall In US Covid Cases, 38% Fall In Deaths In Last 2 Weeks

Biden Signs Covid Origins Bill Into Law

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

Covid Cases, Hospitalizations Fall Nationwide In Last 2 Weeks

FDA Authorizes First At-Home Test To Detect Flu And COVID-19

Read More

COVID-19: Drugs in Development

RELATED NEWS

Snap-on Q4 Results Rise, Top Estimates

Snap-On Inc. Reveals Increase In Q4 Bottom Line, Beats estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Aunt Millie's Our Family White Hot Dog Buns Recalled

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

FDA Clears Eat Just's Good Meat Cultivated Chicken

Attorneys General Of 23 US States Urge Hyundai, Kia To Take Swift Action Against Car Thefts

Kagome Worcester, Chuno, Take Out Tonkatsu Sauces Recalled

Domino's Offering 50% Off Menu-Priced Pizzas Through March 26

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Hoyo, SBC Recalls Frozen, Ready-To-Eat Beef Sambusa Product

Mockingbird Expands Recall To Include Single Strollers

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update

FDA Clears Eat Just's Good Meat Cultivated Chicken

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Pearson In Deal To Sell Pearson Online Learning Services To Regent

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Zai Lab Partner Karuna's Phase 3 Trial Of KarXT In Schizophrenia Meets Primary Endpoint

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

TUI Group To Increase Capital By EUR 1.8 Bln To Repay Debt, Cut Costs

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

PDD Holdings Q4 Profit Rises 43%

Illumina: Icahn's Director Nominees Do Not Add Value To Board

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Spectris Commences Third Tranche Of Share Repurchase Programme

Sandoz Gets FDA Approval For Biosimilar Hyrimoz High-concentration Formulation

Shoe Carnival Q4 GAAP Net Income Rises

TUI Group To Increase Capital By EUR 1.8 Bln To Repay Debt, Cut Costs

Death Toll Linked To Contaminated Eye Drops Rises To Three

Semtech Enters Into Cooperation Agreement With Lion Point Capital - Quick Facts

Accenture plc Q2 Profit Decreases, but beats estimates

Bytes Technology Sees Higher FY23 Results; Stock Up

TELUS Prices $500mln Of Senior Unsecured Notes With 10-year Maturity

Gambling.com Q4 Earnings - Update

Recon Technology Posts Loss In H1; Total Revenues Down 16.3%